| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 963 | 1,017 | 722 | 873 | 1,425 | 1,027 | 1,128 | 1,248 | 1,167 | 945 | 1,365 |
| Expenses | 856 | 877 | 621 | 701 | 1,041 | 763 | 847 | 905 | 845 | 616 | 947 |
| EBITDA | 107 | 140 | 101 | 173 | 384 | 264 | 281 | 343 | 322 | 329 | 418 |
| Operating Profit % | 9 % | 12 % | 11 % | 17 % | 23 % | 24 % | 24 % | 26 % | 27 % | 34 % | 30 % |
| Depreciation | 23 | 25 | 19 | 21 | 30 | 30 | 27 | 28 | 27 | 17 | 23 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 |
| Profit Before Tax | 83 | 115 | 99 | 158 | 355 | 233 | 253 | 314 | 273 | 312 | 395 |
| Tax | 30 | 36 | 38 | 56 | 101 | 57 | 61 | 85 | 72 | 77 | 107 |
| Net Profit | 54 | 79 | 61 | 102 | 254 | 177 | 193 | 230 | 201 | 234 | 294 |
| EPS in ₹ | 32.30 | 47.70 | 56.60 | 505.27 | 153.00 | 107.00 | 116.00 | 138.00 | 121.00 | 141.00 | 176.80 |
Procter & Gamble Health
Procter & Gamble Health
5,260.50
+40.50
(0.78%)
Market Cap
8,732.10 Cr
PE Ratio
29.54
Volume
17,405.00
Day High - Low
5,290.00 - 5,197.50
52W High-Low
6,739.00 - 4,707.00
Key Fundamentals
Market Cap
8,732.10 Cr
EPS
141.00
PE Ratio
29.54
PB Ratio
13.99
Book Value
373.34
EBITDA
328.70
Dividend Yield
2.39 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
43.66
Debt to Equity
0.02
Actual
Company News
View All News
Procter & Gamble Health Limited executed sale of immovable properties in Mumbai on April 30, 2026, recording approximately ₹32 crore profit from the transaction under regulatory compliance.
Procter & Gamble Health Limited disclosed to stock exchanges that it does not qualify as a Large Corporate under SEBI's debt securities framework, with nil outstanding borrowings as of March 31, 2026.
P&G Health Files Q4FY26 Compliance Certificate
Apr 06, 2026
Apr 06, 2026Procter & Gamble Health Limited submits mandatory quarterly certificate under SEBI regulations confirming timely submission of dematerialization details for quarter ended March 31, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,863.20 | #1 4,47,044.09 | 39.96 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 63.20 | |
6,921.50 | 1,83,744.08 | 72.74 | 9,712.00 | 18.67 | 2,191 | -1.02 | 76.54 | |
4,403.90 | 1,49,047.99 | 63.98 | 11,539.40 | 6.99 | 1,911 | 26.24 | 58.43 | |
1,436.70 | 1,16,053.85 | 27.76 | 27,711.70 | -2.46 | 3,783 | -55.32 | 70.81 | |
1,303.60 | 1,08,804.06 | 25.40 | 33,593.30 | -0.44 | 3,998 | -86.05 | 54.59 | |
2,258.20 | 1,03,209.50 | 18.91 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 43.90 | |
2,462.20 | 1,01,640.86 | 55.11 | 12,744.20 | 20.90 | 2,007 | 7.65 | 70.95 | |
991.70 | 99,788.22 | #1 18.80 | 23,511.00 | 18.55 | 4,615 | -0.32 | 66.36 | |
1,510.90 | 87,753.32 | 24.96 | 32,345.60 | 9.43 | 3,484 | 7.59 | 73.72 | |
1,315.50 | 71,018.13 | 77.65 | 6,812.90 | #1 21.03 | 884 | 21.18 | 79.66 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-19.06 %
Net Income Growth
16.62 %
Cash Flow Change
-26.11 %
ROE
16.93 %
ROCE
13.19 %
EBITDA Margin (Avg.)
26.27 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 784 | 879 | 991 | 1,760 | 1,176 | 986 | 888 | 1,101 | 794 | 794 |
| Fixed Assets | 132 | 111 | 115 | 104 | 101 | 104 | 112 | 144 | 129 | 116 |
| Current Assets | 572 | 636 | 752 | 1,534 | 954 | 727 | 608 | 796 | 524 | 526 |
| Capital Work in Progress | 7 | 30 | 9 | 17 | 22 | 39 | 41 | 33 | 6 | 11 |
| Investments | 42 | 28 | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 603 | 711 | 797 | 1,639 | 1,053 | 843 | 736 | 925 | 660 | 667 |
| Total Equity & Liabilities | 784 | 879 | 991 | 1,760 | 1,176 | 986 | 888 | 1,101 | 794 | 794 |
| Current Liabilities | 165 | 186 | 225 | 193 | 227 | 239 | 232 | 304 | 219 | 215 |
| Non Current Liabilities | 27 | 29 | 33 | 27 | 42 | 44 | 40 | 46 | 37 | 42 |
| Total Equity | 592 | 664 | 733 | 1,540 | 906 | 704 | 617 | 751 | 538 | 537 |
| Reserve & Surplus | 575 | 647 | 717 | 1,524 | 890 | 687 | 600 | 734 | 522 | 520 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 4 | 17 | -16 | 1,109 | -483 | -172 | -145 | 116 | -197 | -57 |
| Investing Activities | -68 | -75 | -48 | 1,270 | 165 | -32 | -26 | -22 | -7 | 10 |
| Operating Activities | 84 | 107 | 54 | -130 | 235 | 247 | 170 | 236 | 228 | 169 |
| Financing Activities | -12 | -15 | -22 | -30 | -883 | -387 | -289 | -99 | -418 | -235 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 7.59 % | 6.24 % | 6.40 % | 6.61 % | 7.02 % | 6.87 % | 6.99 % | 7.24 % | 6.97 % | 6.20 % |
| DIIs | 11.48 % | 11.81 % | 8.37 % | 8.53 % | 7.90 % | 8.07 % | 12.62 % | 12.43 % | 12.31 % | 12.30 % | 12.13 % | 12.67 % | 13.73 % | 14.55 % | 14.84 % | 14.71 % | 14.21 % | 14.16 % | 13.91 % | 13.84 % | 13.68 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 24.58 % | 24.49 % | 24.80 % | 24.55 % | 24.81 % | 25.09 % | 24.46 % | 24.33 % | 24.09 % | 23.64 % | 23.43 % | 22.91 % | 22.61 % | 21.82 % | 21.46 % | 21.34 % | 21.90 % | 21.89 % | 22.15 % | 22.43 % | 23.17 % |
| Others | 12.13 % | 11.88 % | 15.01 % | 15.10 % | 15.47 % | 15.02 % | 11.11 % | 11.43 % | 11.78 % | 12.25 % | 12.62 % | 5.02 % | 5.60 % | 5.41 % | 5.28 % | 5.12 % | 5.21 % | 5.14 % | 4.89 % | 4.94 % | 5.14 % |
| No of Share Holders | 0 | 53,075 | 58,818 | 63,525 | 65,537 | 66,289 | 65,729 | 65,148 | 61,030 | 58,856 | 57,919 | 56,730 | 56,778 | 55,923 | 54,792 | 53,736 | 53,993 | 52,478 | 50,006 | 49,302 | 50,883 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 15 | 440 | 0.00 | 230 | 130 | 52.5 | 95 | 260 | 125 | 0.00 |
| Dividend Yield (%) | 1 | 11.91 | 0.00 | 3.71 | 3.25 | 1.12 | 2.02 | 5.05 | 2.6 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 May 2026 |  Quarterly Result Announcement | NA | 26 May 2026 | 4,939.40 | 5,222.20 |
| 06 May 2019 |  Change Of Name | NA | 06 May 2019 | 3,672.50 | 3,672.50 |
| 05 Nov 2021 |  Dividend | ₹ 40.00 /share | 02 Nov 2021 | 5,424.55 | 5,444.20 |
| 05 Nov 2021 | Dividend | ₹ 90.00 /share | 02 Nov 2021 | 5,374.30 | 5,444.20 |
| 13 May 2022 | Dividend | ₹ 41.00 /share | 12 May 2022 | 4,409.35 | 4,294.00 |
| 17 Nov 2022 | Dividend | ₹ 11.50 /share | 15 Nov 2022 | 4,190.70 | 4,290.60 |
| 23 Nov 2022 |  Annual General Meeting | NA | 23 Nov 2022 | 4,279.25 | 4,163.45 |
| 13 Feb 2023 | Dividend | ₹ 45.00 /share | 13 Feb 2023 | 4,096.95 | 4,702.90 |
| 24 Nov 2023 | Dividend | ₹ 50.00 /share | 23 Nov 2023 | 5,360.10 | 5,072.15 |
| 30 Nov 2023 | Annual General Meeting | NA | 30 Nov 2023 | 5,343.35 | 5,154.75 |
| 14 Feb 2024 | Dividend | ₹ 50.00 /share | 14 Feb 2024 | 5,136.60 | 5,503.95 |
| 14 Feb 2024 | Dividend | ₹ 150.00 /share | 14 Feb 2024 | 5,136.60 | 5,503.95 |
| 04 Nov 2024 | Quarterly Result Announcement | NA | 04 Nov 2024 | 5,251.05 | 5,196.40 |
| 29 Nov 2024 | Dividend | ₹ 60.00 /share | 28 Nov 2024 | 5,422.90 | 5,168.55 |
| 05 Dec 2024 | Annual General Meeting | NA | 05 Dec 2024 | 5,373.45 | 5,346.85 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 5,446.35 | 5,259.70 |
| 21 Feb 2025 | Dividend | ₹ 80.00 /share | 21 Feb 2025 | 5,259.70 | 5,345.60 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 5,410.00 | 5,729.50 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 5,876.30 | 5,895.50 |
| 22 Aug 2025 | Dividend | ₹ 45.00 /share | 22 Aug 2025 | 5,729.50 | 6,338.50 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 6,185.55 | 6,298.50 |
| 05 Nov 2025 | Quarterly Result Announcement | NA | 05 Nov 2025 | 6,275.75 | 6,066.00 |
| 06 Feb 2026 | Quarterly Result Announcement | NA | 06 Feb 2026 | 5,637.25 | 5,244.00 |
| 12 Feb 2026 | Dividend | ₹ 110.00 /share | 12 Feb 2026 | 5,244.00 | 5,483.00 |
| 12 Feb 2026 | Dividend | ₹ 50.00 /share | 12 Feb 2026 | 5,244.00 | 5,483.00 |
Announcements
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Sale Of Immovable PropertiesApr 30, 2026
Apr 30, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 06, 2026
Apr 06, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Apr 06, 2026Board Meeting Intimation for Intimation Of Board MeetingMar 27, 2026
Mar 27, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health LimitedFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 06, 2026
Feb 06, 2026Record DateFeb 06, 2026
Feb 06, 2026Unaudited Financial Results For The Quarter Ended December 31 2025Feb 06, 2026
Feb 06, 2026Corporate Action-Board approves DividendFeb 06, 2026
Feb 06, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On February 6 2026Feb 06, 2026
Feb 06, 2026Update on board meetingJan 21, 2026
Jan 21, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Jan 16, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On February 6 2026.Dec 26, 2025
Dec 26, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 18, 2025
Nov 18, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 17, 2025
Nov 17, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 05, 2025
Nov 05, 2025Outcome Of Board Meeting For The Quarter Ended September 30 2025Nov 05, 2025
Nov 05, 2025Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended September 30 2025Nov 05, 2025
Nov 05, 2025Revision of Board MeetingOct 20, 2025
Oct 20, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 20, 2025
Oct 20, 2025Allotment Of DIN To Mr. Shashank Srowthy Executive DirectorOct 01, 2025
Oct 01, 2025Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On November 5 2025Sep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Sep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 08, 2025
Sep 08, 2025Change In Senior Management Personnel Of The CompanySep 01, 2025
Sep 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Aug 29, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 29, 2025
Aug 29, 2025Intimation Regarding IEPFs 100 Days Campaign - Saksham NiveshakAug 26, 2025
Aug 26, 2025Reg. 34 (1) Annual Report.Aug 26, 2025
Aug 26, 2025Approval Of Promoter Reclassification Pursuant To Companys Application Dated June 27 2018Aug 18, 2025
Aug 18, 2025Record Date For Annual General MeetingAug 06, 2025
Aug 06, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 06, 2025
Aug 06, 2025Annual Report For The Financial Year 2024-25 And Notice Calling The 58Th Annual General Meeting Of The CompanyAug 06, 2025
Aug 06, 2025Press Release For The Quarter Ended June 30 2025Aug 01, 2025
Aug 01, 2025Unaudited Financial Results For Quarter Ended June 30 2025Aug 01, 2025
Aug 01, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 01, 2025
Aug 01, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Jul 15, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 27, 2025
Jun 27, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On August 1 2025Jun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 17, 2025
Jun 17, 2025Analysts/Institutional Investors - PresentationJun 16, 2025
Jun 16, 2025Change In Senior Management Personnel Of The Company
Jun 11, 2025
Jun 11, 2025Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health LimitedJun 09, 2025
Jun 09, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 55.36
ATR(14)
Volatile 126.52
STOCH(9,6)
Neutral 54.90
STOCH RSI(14)
Oversold 16.90
MACD(12,26)
Bearish -1.28
ADX(14)
Strong Trend 34.44
UO(9)
Bearish 50.29
ROC(12)
Uptrend And Accelerating 1.58
WillR(14)
Neutral -56.66
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
